Current stock page

Catalysts

ADMA Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

ADMAADMA Biologics, Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$13.68+$0.44 (+3.32%)

Latest quote

  • Momentum
    91
  • Value
    80
  • Quality
    72
  • Risk resilience
    56
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 24, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 78/100

Momentum 91/100 and sentiment — before the next covered event.

Recent coverage
2 articles

Updated Nov 15, 2026 · Sentiment 23.84%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 91/100AIQ Edge 10/10 Sector Leader
Beat rate
38%
3 of 8 reported periods
Average surprise
+1.2%
Across covered historical reports
Latest result
+16.9%
Nov 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—$0.20$0.23+16.9%$138.11M$141.1M
Aug 5, 2026—$0.16$0.16-2.0%$125.34M$124.4M
May 6, 2026—$0.19$0.19-1.7%$139.98M$114.49M
Feb 25, 2026—$0.19$0.20+8.1%$139.6M$139.16M
Nov 5, 2025—$0.16$0.16+0.0%$139.8M$134.22M
Aug 6, 2025—$0.14$0.15+7.1%$130.3M$121.98M
May 7, 2025—$0.16$0.14-12.5%$121.8M$114.8M
Mar 3, 2025—$0.15$0.14-6.7%$108.65M$117.55M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
3
Buy
1
Hold
12-month analyst target
$18.00
+31.58% versus current price
Based on 4 analyst observations. Targets are estimates, not predictions.
Low target
$18.00
+31.58% vs latest price
Average target
$18.00
+31.58% vs latest price
High target
$18.00
+31.58% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 24, 2027

Next known earnings or reporting date.

EPS estimate$0.22

Current analyst expectation for the upcoming report.

Revenue estimate$154.79M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score91

Where event reaction would show up first.

AIQ score78/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
4
Average target
$18.00
Target upside
31.58%
Target range
$18.00 - $18.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
zacks.com · Oct 8, 2026

ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Adma Biologics (ADMA). This makes it worthwhile to examine what the stock has in store.

seekingalpha.com · Sep 2, 2026

ADMA Biologics: Maybe The Bears Are Right (Rating Downgrade) (NASDAQ:ADMA)

ADMA Biologics stock is downgraded to Hold as FY26 guidance drops and growth slows. See ADMA's ASCENIV outlook, BIVIGAM decline, and $9.52 DCF.

Open full news and sentiment

ADMA Catalysts FAQ

What are the next catalysts for ADMA stock?

ADMA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ADMA stock?

Upcoming events that could move ADMA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ADMA's next earnings report affect the stock?

ADMA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ADMA stock higher?

ADMA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ADMA stock?

ADMA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.